Chronic Pain
Study register · detail Retrospektive Kohortenstudie · Chronic Pain · 2020

The Impact of Medical Cannabis on Intermittent and Chronic Opioid Users with Back Pain: How Cannabis Diminished Prescription Opioid Usage

Mixed GRADE Very low 55 citations
Samplen = 61 Pat.
DurationMedian 6,4 years
EndpointOpioid cessation rate
Blindingn.a.
DesignRetrospektive Kohortenstudie
Cannabinoidvollspektrum
Key finding

Cannabis enabled complete discontinuation of opioids in a good half of patients, in some cases with no effect or with an increase in opioid use.

Summary

Retrospective cohort study (n=61 opioid users with back pain): 50,8% stopped all opioid intake after cannabis recommendation; of the remaining 29 patients, 31% reduced opioid dose; higher cannabis dose was the only predictor for opioid cessation.

P
PopulationAdults with chronic back pain (ICD-10 M54.5) and opioid use, n=61
I
InterventionMedical cannabis (recommendation for pain relief, various dosages)
O
Outcome50,8 % of patients stopped opioid use completely; higher cannabis doses predicted opioid cessation (only significant predictor variable)
Confidence in the evidence
Very low

The lowest GRADE level, the effect estimate remains uncertain.

Downgraded for
Imprecision
Quality profile
Sample size
Blinding
Effect size Mixed
Citations / year
Authors
Takakuwa K M, Hergenrather J Y, Shofer F S et al.
DOI 10.1089/can.2019.0039
Design: Retrospektive Kohortenstudie
Share
Abstract
<b>Objective:</b> To determine if cannabis may be used as an alternative or adjunct treatment for intermittent and chronic prescription opioid users. <b>Design:</b> Retrospective cohort study. <b>Setting:</b> A single-center cannabis medical practice site in California. <b>Patients:</b> A total of 180 patients who had a chief complaint of low back pain were identified (<i>International Classification of Diseases</i>, 10th Revision, code M54.5). Sixty-one patients who used prescription opioids were analyzed. <b>Interventions:</b> Cannabis recommendations were provided to patients as a way to mitigate their low back pain. <b>Outcome Measures:</b> Number of patients who stopped opioids and change in morphine equivalents. <b>Results:</b> There were no between-group differences based on demographic, experiential, or attitudinal variables. We found that 50.8% were able to stop all opioid usage, which took a median of 6.4 years (IQR=1.75-11 years) after excluding two patients who transitioned off opioids by utilizing opioid agonists. For those 29 patients (47.5%) who did not stop opioids, 9 (31%) were able to reduce opioid use, 3 (10%) held the same baseline, and 17 (59%) increased their usage. Forty-eight percent of patients subjectively felt like cannabis helped them mitigate their opioid intake but this sentiment did not predict who actually stopped opioid usage. There were no variables that predicted who stopped opioids, except that those who used higher doses of cannabis were more likely to stop, which suggests that some patients might be able to stop opioids by using cannabis, particularly those who are dosed at higher levels. <b>Conclusions:</b> In this long-term observational study, cannabis use worked as an alternative to prescription opioids in just over half of patients with low back pain and as an adjunct to diminish use in some chronic opioid users.

The impediment to action advances action. — Marcus Aurelius